{
  "pmcid": "9266992",
  "sha256": "498e14d46dee4603c9ae3d081b711bd0de5805918400152f6a38515eaeba3c3b",
  "timestamp_utc": "2025-11-09T23:00:49.177429+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.480861344537814,
    "reading_ease": 30.413280812324956,
    "word_count": 238
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Autologous Bone Marrow Mononuclear Cells for Critical Limb Ischaemia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly allocated"
      },
      "Participants": {
        "score": 2,
        "evidence": "involving 176 participants diagnosed with CLI"
      },
      "Intervention": {
        "score": 2,
        "evidence": "intramuscular BMMNCs or control (conventional therapy, diluted autologous peripheral blood, or saline)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy of intramuscular transplantation of autologous bone marrow mononuclear cells (BMMNCs) in CLI patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcomes were all-cause mortality, pain, and amputation, assessed over a 12-month period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not specified."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 176 participants were randomised: 88 to the BMMNC group and 88 to the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was intention-to-treat."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Amputation rates showed a possible small effect (RR 0.52, 95% CI 0.27 to 0.99)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant differences were observed in side effects (RR 2.13, 95% CI 0.50 to 8.97)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}